Skip to content
Financing

Finance Lease, Principal Payments

West Pharmaceutical Services Finance Lease, Principal Payments remained flat by 0.0% to $300K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 50.0%, from $200K to $300K.

Analysis

StatementCash Flow Statement
SectionFinancing
First reportedQ1 2022
Last reportedQ1 2026Apr 23, 2026
Metric ID: financing_finance_lease_principal_payments

Historical Data

17 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$0$0$0$0$0$0$0$100K$100K$22.9M$300K$100K$200K$300K$300K$300K$300K
QoQ Change+0.0%>999%-98.7%-66.7%+100.0%+50.0%+0.0%+0.0%+0.0%
YoY Change+0.0%+100.0%-98.7%+0.0%+200.0%+50.0%
Range$0$22.9M
Avg YoY Growth+41.9%
Median YoY Growth+25.0%
Current Streak5 quarters growth

Frequently Asked Questions

What is West Pharmaceutical Services's finance lease, principal payments?
West Pharmaceutical Services (WST) reported finance lease, principal payments of $300K in Q1 2026.
How has West Pharmaceutical Services's finance lease, principal payments changed year-over-year?
West Pharmaceutical Services's finance lease, principal payments increased by 50.0% year-over-year, from $200K to $300K.